UBS O'Connor’s Covetrus, Inc. Common Stock CVET Stock Holding History

UBS O'Connor’s Portfolio CVET Stock Details CVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,870,220	Closed	-$39M	–	904
2022 Q3	$39M	Buy	1,870,220 +373,576	+25%	+$7.78M	0.44%	31
2022 Q2	$31.1M	Buy	+1,496,644	New	+$26.6M	0.32%	39
2021 Q3	–	Sell	-205,000	Closed	-$5.54M	–	1025
2021 Q2	$5.54M	Buy	+205,000	New	+$5.74M	0.05%	191

Other funds holding CVET

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

UBS O'Connor's CVET Position: Q4 2022 in Review

UBS O'Connor sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 1,870,220 shares — an estimated $39M sold.

UBS O'Connor first reported a position in CVET in Q2 2021 and held it in 3 quarters. The position peaked at $39M in Q3 2022. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

UBS O'Connor reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
UBS O'Connor sold 1,870,220 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $39M.
UBS O'Connor first reported a position in Covetrus, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
UBS O'Connor's Covetrus, Inc. Common Stock position peaked at $39M in Q3 2022.
5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.